Osteoclasts in normal and adjuvant arthritis bone tissues express the mRNA for both type I and II interleukin-1 receptors

Laboratory Investigation

Volumn 75, Issue 5, 1996, Pages 677-687

  Xu, Li Xin ^a   Kukita, Toshio ^a   Nakano, Yoshio ^a   Yu, Hao ^a   Hotokebuchi, Takao ^b   Kuratani, Tsuyoshi ^a   Iijima, Tadahiko ^a   Koga, Toshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR;

ADJUVANT DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; FEMALE; IN SITU HYBRIDIZATION; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; OSTEOLYSIS; PRIORITY JOURNAL; RAT; TIBIA;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BONE AND BONES; BONE RESORPTION; FEMALE; GENE EXPRESSION; INTERLEUKINS; MICE; OSTEOCLASTS; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; RECEPTORS, INTERLEUKIN-1; RNA, MESSENGER; TIBIA;

EID: 2642686612     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Altschul SF, Gish W, Miller W, Myers EW, and Lipman DJ (1990). Basic local alignment search tool. J Mol Biol 215:403-410.
2. Bird TA and Saklatvala J (1986). Identification of a common class of high affinity receptors for both types of porcine interleukin-1 on connective tissue cells. Nature 324:263-266.
3. Boyce BF, Aufdemorte TB, Garrett IR, Yates AJP, and Mundy GR (1989). Effects of interleukin-1 on bone turnover in normal mice. Endocrinology 125:1142-1150.
4. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri J, Dower SK, Sims JE, and Mantovani A (1993). Interleukin-1 type II receptor: A decoy target for IL-1 that is regulated by IL-4. Science 261:472-475.
5. Del Pozo E, Graeber M, Elford P, and Payne T (1990). Regression of bone and cartilage loss in adjuvant arthritic rats after treatment with cyclosporin A. Arthritis Rheum 33:247-252.
6. Dewhirst FE, Stashenko PP, Mole JE, and Tsurumachi T (1985). Purification and partial sequence of human osteoclast-activating factor: Identity with interleukin 1 beta. J Immunol 135:2562-2568.
7. Deyerle KL, Sims JE, Dower SK, and Bothwell MA (1992). Pattern of IL-1 receptor gene expression suggests role in noninflammatory processes. J Immunol 149:1657-1665.
8. Dinarello CA (1991). Interleukin-1 and interleukin-1 antagonism. Blood 77:1627-1652.
9. Dinarello CA (1994). The interleukin-1 family: 10 years of discovery. FASEB J 8:1314-1325.
10. Francis MD, Hovancik K, and Boyce RW (1989). A diphosphonate which prevents bone erosion and preserves joint architecture in experimental arthritis. Int J Tissue React 11(Suppl 5):239-252.
11. Garrett IR, Guise TA, Bonewald LF, Chizzonite R, and Mundy GR (1993). Evidence that interleukin-1 mediates its effects on bone resorption via the 80 kilodalton interleukin-1 receptor. Calcif Tissue Int 52:438-441.
12. Göthlin G and Ericsson JLE (1976). The osteoclast: Review of ultrastructure, origin, and structure-function relationship. Clin Orthop 120:201-228.
13. Gowen M and Mundy GR (1986). Actions of recombinant interleukin 1, interleukin 2 and interferon gamma on bone resorption in vitro. J Immunol 136:2478-2482.
14. Gowen M, Wood DD, Ihrie EJ, McGuire MKB, and Russell RGG (1983). An interleukin 1 like factor stimulates bone resorption in vitro. Nature 306:378-380.
15. Hayashida K, Ochi T, Fujimoto M, Owaki H, Shimaoka Y, Ono K, and Matsumoto K (1992). Bone marrow changes in adjuvant-induced and collagen-induced arthritis. Arthritis Rheum 35:241-245.
16. Hirota S, Ito A, Morii E, Wanaka A, Tohyama M, Kitamura Y, and Nomura S (1992). Localization of mRNA for c-kit receptor and its ligand in the brain of adult rats: An analysis using in situ hybridization. Mol Brain Res 15:47-54.
17. Hopkins SJ, Humphreys M, and Jayson MIV (1988). Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1. Clin Exp Immunol 72:422-427.
18. Jandinski JJ (1988). Osteoclast activating factor is now interleukin-1 beta: Historical perspective and biological implications. J Oral Pathol 17:145-152.
19. Jimi E, Ikebe T, Takahashi N, Hirata M, Suda T, and Koga T (1996). Interleukin-1 a activates an NF-κB-like factor in osteoclast-like cells. J Biol Chem 271:4605-4608.
20. 3H) tetracycline excretion from prelabeled mice. J Bone Miner Res 3:621-627.
21. Lorenzo JA, Sousa SL, Alander C, Raisz LG, and Dinarello CA (1987). Comparison of the bone-resorbing activity in the supernatants from phytohemagglutinin-stimulated human peripheral blood mononuclear cells with that of cytokines through the use of an antiserum to interleukin 1. Endocrinology 121:1164-1170.
22. Martel-Pelletier J, McCollum R, DiBattista JA, Faure MP, Chin JA, and Fournier S (1992). The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes: Identification as the type I receptor and analysis of binding kinetics and biologic function. Arthritis Rheum 35:530-540.
23. McMahan CJ, Slack JL, Mosley B, Cosman D, Lupton SD, Brunton LL, Grubin CE, Wignall JM, Jenkins NA, Brannan CI, Copeland NG, Huebner K, Croce CM, Canrizzarro LA, Benjamin D, Dower SK, Spriggs MK, and Sims JE (1991). A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J 10:2821-2832.
24. Mohr M and Wild A (1976). Adjuvant arthritis. Arzneimittelforschung 26:1860-1866.
25. Mundy GR (1993). Cytokines and growth factors in the regulation of bone remodeling. J Bone Miner Res 8:S505-S510.
26. Pacifici R, Rifas L, McCracken R, Vered I, McMurty C, Avioli LV, and Peck WA (1989). Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA 86:2398-2402.
27. Pacifici R, Rifas L, Teitelbaum S, Slatopolsky E, McCracken R, Bergfeld M, Lee W, Avioli LV, and Peck WA (1987). Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc Natl Acad Sci USA 84:4616-4620.
28. Pearson CM (1956). Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc Soc Exp Biol Med 91:95-101.
29. Pearson CM and Wood FD (1963). Studies of arthritis and other lesions induced in rats by the injection of mycobacterial adjuvant. Am J Pathol 42:73-95.
30. Pelletier JP and Martel-Pelletier J (1989). Evidence for the involvement of interleukin 1 in human osteoarthritic cartilage degradation: Protective effect of NSAID. J Rheumatol 16:19-27.
31. Pelletier JP, McCollum R, Cloutier JM, and Martel-Pelletier J (1995). Synthesis of metalloproteases and IL-6 in human osteoarthritic synovial membrane is an IL-1 mediated process. J Rheumatol 22(Suppl 43):109-114.
32. Pfeilschifter J, Chenu C, Bird A, Mundy GR, and Roodman GD (1989). Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro. J Bone Miner Res 4:113-118.
33. Qu Z, Picou M, Dang TT, Angell E, Planck SR, Hart CE, and Rosenbaum JT (1994). Immunolocalization of basic fibroblast growth factor and platelet-derived growth factor-A during adjuvant arthritis in the Lewis rat. Am J Pathol 145:1127-1139.
34. Re F, Muzio M, Rossi MD, Polentarutti N, Giri JG, Mantovani A, and Colotta F (1994). The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: Characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. J Exp Med 179:739-743.
35. 2 stimulation of cAMP production. J Immunol 145:1231-1237.
36. Shen V, Cheng S-L, Kohler NG, and Peck WA (1990). Characterization and hormonal modulation of IL-1 binding in neonatal mouse osteoblast-like cells. J Bone Miner Res 5:507-515.
37. Sims JE, Acres RB, Grubin CE, McMahan CJ, Wignall JM, March CJ, Friend D, Alpert AR, Gillis S, Urdal DL, and Dower SK (1989). Cloning the interleukin 1 receptor from human T cells. Proc Natl Acad Sci USA 86:8946-8950.
38. Sims JE, Gayle MA, Slack JL, Alderson MR, Bird TA, Giri JG, Colotta F, Re F, Mantovani A, Shanebeck K, Grabstein KH, and Dower SK (1993). Interleukin-1 signaling occurs exclusively via the type I receptor. Proc Natl Acad Sci USA 90:6155-6159.
39. Sims JE, March CJ, Cosman D, Widmer MB, MacDonald HR, McMahan CJ, Grubin CE, Wignall JM, Jackson JL, Call SM, et al (1988). cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 241: 585-589.
40. Slack J, McMahan CJ, Waugh S, Schooley K, Spriggs MK, Sims JE, and Dower SK (1993). Independent binding of interleukin-1α and interleukin-1β to type I and type II interleukin-1 receptors. J Biol Chem 268:2513-2524.
41. Stylianou E, O'Neill LAJ, Rawlinson L, Edbrooke MR, Woo P, and Saklatvala J (1992). Interleukin-1 induces NFκB through its type I but not type II receptor in lymphocytes. J Biol Chem 267:15836-15841.
42. Thomson BM, Saklatvala J, and Chambers TJ (1986). Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts. J Exp Med 164:104-112.
43. Touw JA, Hemrika-Wagner AM, and Vermeiden JPW (1980). An electron Microscopic, enzyme cytochemical study on the localization of lactate dehydrogenase (LDH) in osteoclasts and peritoneal macrophages of the rat and its implication for the process of bone resorption and the origin of osteoclasts. Cell Tissue Res 209:111-116.
44. Watnick AS (1975). The adjuvant arthritic rat: A tool for discovering antiarthritic drugs. In: Rosenthale ME and Mansmann HC, editors. Immunopharmacology. New York: Spectrum, 155-171.
45. Yu H and Ferrier J (1993). Interleukin-1 alpha induces a sustained increase in cytosolic free calcium in cultured rabbit osteoclasts. Biochem Biophys Res Commun 191:343-350.